Skip to content

The clinical effect of partial splenic artery embolization predicted by changes of splenic arterial hemodynamic parameters

The clinical effect of partial splenic artery embolization predicted by changes of splenic arterial hemodynamic parameters

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085562
Enrollment
Unknown
Registered
2024-06-12
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis with hypersplenism

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of cirrhosis with hypersplenism; Bone marrow cell examination indicated normal or active bone marrow hyperplasia ? Liver function Child-Pugh A, B grade; ECOG score =3 points; ? The age is between 18 and 75 years old.

Exclusion criteria

Exclusion criteria: ?Liver function Child-Pugh C grade, ECOG score > 3 points; ? Severe coagulation dysfunction and can not be corrected; ? Acute infection or acute phase of chronic infection; ? Bone marrow aspiration results suggest bone marrow suppression; ? Patients with abnormal origin of hepatic artery discovered through abdominal trunk angiography.

Design outcomes

Primary

MeasureTime frame
Splenic artery pressure;blood platelet count;Splenic embolized area;

Secondary

MeasureTime frame
Leukocyte count;

Countries

China

Contacts

Public ContactJian Tang

The First Affiliated Hospital of University of South China

tangjiancrk@163.com+86 138 7574 8696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026